Literature DB >> 14692559

Expression of KIT (CD117) in biphasic pulmonary blastoma. Novel data on histogenesis.

T Hansen1, F Bittinger, C Kortsik, B Wagner, C J Kirkpatrick.   

Abstract

Biphasic pulmonary blastoma (BPB) is a rare primary neoplasm of the lung and its histogenesis is still uncertain. It has been proposed that BPB is derived from mesoderm or endoderm. Others suggested an origin from a single pluripotential cell. We present a case of a BPB with emphasis on expression of the stem cell factor receptor KIT (CD117). We describe a 61-year-old male patient with a BPB of the upper right lobe. Immunohistochemical analysis was performed using a panel of several antibodies including anti-CD117. Strong cytoplasmic expression of CD117 was found in the epithelium (cytokeratin-positive) as well as in the spindle cells (cytokeratin-negative). Expression of CD117 in both mesenchymal and epithelial cells suggests a single origin and supports the idea that BPB arises from a pluripotential cell that can differentiate into both stromal and epithelial morphologies. The role of CD117 in the pathogenesis of BPB and its possible therapeutic relevance require further investigation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14692559     DOI: 10.1007/s00408-003-1021-2

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  13 in total

1.  Immunohistochemical characterization of pulmonary blastoma.

Authors:  K Berean; L D Truong; A W Dudley; P T Cagle
Journal:  Am J Clin Pathol       Date:  1988-06       Impact factor: 2.493

Review 2.  CD117 (KIT): a diverse protein with selective applications in surgical pathology.

Authors:  Pamela C Gibson; Kumarasen Cooper
Journal:  Adv Anat Pathol       Date:  2002-01       Impact factor: 3.875

3.  Expression of c-kit and kit ligand proteins in normal human tissues.

Authors:  A Lammie; M Drobnjak; W Gerald; A Saad; R Cote; C Cordon-Cardo
Journal:  J Histochem Cytochem       Date:  1994-11       Impact factor: 2.479

4.  Expression of the c-Kit receptor and its ligand SCF in non-small-cell lung carcinomas.

Authors:  T Pietsch; M R Nicotra; R Fraioli; H K Wolf; M Mottolese; P G Natali
Journal:  Int J Cancer       Date:  1998-01-19       Impact factor: 7.396

5.  p53 and K-ras mutational genotyping in pulmonary carcinosarcoma, spindle cell carcinoma, and pulmonary blastoma: implications for histogenesis.

Authors:  V A Holst; S Finkelstein; T V Colby; J L Myers; S A Yousem
Journal:  Am J Surg Pathol       Date:  1997-07       Impact factor: 6.394

6.  The selective tyrosine kinase inhibitor STI571 inhibits small cell lung cancer growth.

Authors:  G W Krystal; S Honsawek; J Litz; E Buchdunger
Journal:  Clin Cancer Res       Date:  2000-08       Impact factor: 12.531

7.  Patterns of keratin polypeptides in 110 biphasic, monophasic, and poorly differentiated synovial sarcomas.

Authors:  M Miettinen; J Limon; A Niezabitowski; J Lasota
Journal:  Virchows Arch       Date:  2000-09       Impact factor: 4.064

8.  Pulmonary blastomas.

Authors:  M N Koss; L Hochholzer; T O'Leary
Journal:  Cancer       Date:  1991-05-01       Impact factor: 6.860

9.  Pulmonary blastoma. An immunohistochemical analysis with comparison with fetal lung in its pseudoglandular stage.

Authors:  S A Yousem; M R Wick; P Randhawa; J C Manivel
Journal:  Am J Clin Pathol       Date:  1990-02       Impact factor: 2.493

10.  c-KIT and c-KIT ligand (SCF) in synovial sarcoma (SS): an mRNA expression analysis in 23 cases.

Authors:  E Tamborini; D Papini; A Mezzelani; C Riva; A Azzarelli; G Sozzi; M A Pierotti; S Pilotti
Journal:  Br J Cancer       Date:  2001-08-03       Impact factor: 7.640

View more
  1 in total

1.  Biphasic pulmonary blastoma: An unusual presentation with chest wall, rib, and pleural involvement.

Authors:  Ramakant Dixit; Nalin Joshi; Lokendra Dave
Journal:  Lung India       Date:  2014-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.